1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Partial Seizure Global Clinical Trials Review, H2, 2014

Partial Seizure Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, “Partial Seizure Global Clinical Trials Review, H2, 2014" provides data on the Partial Seizure clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Partial Seizure. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Partial Seizure. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Partial Seizure Global Clinical Trials Review, H2, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Partial Seizure 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Partial Seizure to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Partial Seizure to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Partial Seizure 25
Subjects Recruited Over a Period of Time 29
Clinical Trials by Sponsor Type 30
Prominent Sponsors 31
Top Companies Participating in Partial Seizure Therapeutics Clinical Trials 32
Prominent Drugs 34
Clinical Trial Profiles 35
Clinical Trial Overview of Top Companies 35
UCB S.A. 35
Clinical Trial Overview of UCB S.A. 35
Pfizer Inc. 40
Clinical Trial Overview of Pfizer Inc. 40
Eisai Co., Ltd. 44
Clinical Trial Overview of Eisai Co., Ltd. 44
Novartis AG 47
Clinical Trial Overview of Novartis AG 47
Johnson and Johnson 50
Clinical Trial Overview of Johnson and Johnson 50
GlaxoSmithKline plc 52
Clinical Trial Overview of GlaxoSmithKline plc 52
Bial - Portela and Ca, S.A. 54
Clinical Trial Overview of Bial - Portela and Ca, S.A. 54
SK Holdings Co., Ltd. 55
Clinical Trial Overview of SK Holdings Co., Ltd. 55
Upsher-Smith Laboratories, Inc. 56
Clinical Trial Overview of Upsher-Smith Laboratories, Inc. 56
Abbott Laboratories 57
Clinical Trial Overview of Abbott Laboratories 57
Clinical Trial Overview of Top Institutes / Government 58
National Institute of Neurological Disorders and Stroke 58
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 58
Emory University 59
Clinical Trial Overview of Emory University 59
Oregon Health and Science University 60
Clinical Trial Overview of Oregon Health and Science University 60
Kyoto University 61
Clinical Trial Overview of Kyoto University 61
National Center for Complementary and Alternative Medicine 62
Clinical Trial Overview of National Center for Complementary and Alternative Medicine 62
Hadassah Medical Organization 63
Clinical Trial Overview of Hadassah Medical Organization 63
University of Pennsylvania 64
Clinical Trial Overview of University of Pennsylvania 64
Lawson Health Research Institute 65
Clinical Trial Overview of Lawson Health Research Institute 65
Massachusetts General Hospital 66
Clinical Trial Overview of Massachusetts General Hospital 66
University of California, Davis 67
Clinical Trial Overview of University of California, Davis 67
Five Key Clinical Profiles 68
Appendix 179
Abbreviations 179
Definitions 179
Research Methodology 180
Secondary Research 180
About GlobalData 181
Contact Us 181
Disclaimer 181
Source 181

List of Tables
Partial Seizure Therapeutics, Global, Clinical Trials by Region, 2014* 7
Partial Seizure Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Partial Seizure Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Partial Seizure Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Partial Seizure Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Partial Seizure Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Partial Seizure Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Partial Seizure Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Partial Seizure to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Partial Seizure Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Partial Seizure Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Partial Seizure to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Partial Seizure Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Partial Seizure Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Partial Seizure Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Partial Seizure Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Partial Seizure Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Partial Seizure Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Partial Seizure Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Partial Seizure Therapeutics, Global, Withdrawn Clinical Trials, 2014* 26
Partial Seizure Therapeutics, Global, Terminated Clinical Trials, 2014* 27
Partial Seizure Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 29
Partial Seizure Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 30
Partial Seizure Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 31
Partial Seizure Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 33
Partial Seizure Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 34
Partial Seizure Therapeutics Clinical Trials Market, Global, Clinical Trials by UCB S.A., 2014* 35
Partial Seizure Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 40
Partial Seizure Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2014* 44
Partial Seizure Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 47
Partial Seizure Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson and Johnson, 2014* 50
Partial Seizure Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 52
Partial Seizure Therapeutics Clinical Trials Market, Global, Clinical Trials by Bial - Portela and Ca, S.A., 2014* 54
Partial Seizure Therapeutics Clinical Trials Market, Global, Clinical Trials by SK Holdings Co., Ltd., 2014* 55
Partial Seizure Therapeutics Clinical Trials Market, Global, Clinical Trials by Upsher-Smith Laboratories, Inc., 2014* 56
Partial Seizure Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2014* 57
Partial Seizure Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2014* 58
Partial Seizure Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2014* 59
Partial Seizure Therapeutics Clinical Trials Market, Global, Clinical Trials by Oregon Health and Science University, 2014* 60
Partial Seizure Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto University, 2014* 61
Partial Seizure Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Complementary and Alternative Medicine, 2014* 62
Partial Seizure Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2014* 63
Partial Seizure Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2014* 64
Partial Seizure Therapeutics Clinical Trials Market, Global, Clinical Trials by Lawson Health Research Institute, 2014* 65
Partial Seizure Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014* 66
Partial Seizure Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Davis, 2014* 67

List of Figures
Partial Seizure Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Partial Seizure Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Partial Seizure Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Partial Seizure Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Partial Seizure Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Partial Seizure Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Partial Seizure Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Partial Seizure Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Partial Seizure to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Partial Seizure Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Partial Seizure Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Partial Seizure to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Partial Seizure Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Partial Seizure Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Partial Seizure Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Partial Seizure Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Partial Seizure Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Partial Seizure Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Partial Seizure Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 29
Partial Seizure Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 30
Partial Seizure Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 31
Partial Seizure Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 32
Partial Seizure Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 34
GlobalData Methodology 180

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.